|
Granier F. Invasive fungal infections.Epidemiology and new therapies [J]. Presse Medicale, 2000, (37):2051.
|
|
Ostrosky-Zeichner L, Pappas P G. Invasive candidiasis in the intensive care unit [J]. Critical Care Medicine, 2006(3):857.
|
|
耿良权, 刘会兰, 孙自敏. 异基因造血干细胞移植并发肺部侵袭性真菌感染及其影响因素研究 [J]. 中国临床保健杂志, 2009(1):30.doi: 10.3969/j.issn.1672-6790.2009.01.012.
|
|
索新华, 白立炜, 海洁. 糖尿病并齿龈肺部侵袭性曲霉菌细菌混合性感染病例分析 [J]. 新乡医学院学报, 2007(6):608.doi: 10.3969/j.issn.1004-7239.2007.06.027.
|
|
杨迎梅, 田丽梅, 张永萍. 两性霉素B治疗白血病肺部真菌感染的护理 [J]. 蚌埠医学院学报, 2008(1):108.doi: 10.3969/j.issn.1000-2200.2008.01.047.
|
|
Ahmad S R, Singer S J, Leissa B G. Congestive heart failure associated with itraconazole [J]. LANCET, 2001, (9270):1766.doi: 10.1016/S0140-6736(00)04891-1.
|
|
朱飞波, 周郁鸿. 米卡芬净治疗恶性血液病合并侵袭性真菌病13例 [J]. 实用临床医药杂志, 2009(2):65.doi: 10.3969/j.issn.1672-2353.2009.03.020.
|
|
荣令, 周新. 米卡芬净单药及联合两性霉素B对小鼠侵袭性肺曲霉病的治疗作用 [J]. 实用临床医药杂志, 2008(7):12.doi: 10.3969/j.issn.1672-2353.2008.11.004.
|
|
中华医学会重症医学分会. 重症患者侵袭性真菌感染诊断和治疗指南 [J]. 中华内科杂志, 2007, (11):960.doi: 10.3760/j.issn:0578-1426.2007.11.031.
|
|
吴菊芳, 张婴元, 汪复. 注射用两性霉素B胆固醇酰硫酸钠治疗30例深部真菌感染 [J]. 中国感染与化疗杂志, 2002(1):20.doi: 10.3321/j.issn:1009-7708.2002.01.005.
|
|
程思远. 慢性阻塞性肺疾病继发真菌感染65例病原菌分布及耐药性分析 [J]. 新乡医学院学报, 2009(1):73.
|
|
Pappas P G, Rex J H, Sobel J D. Guidelines for treatment of candidiasis [J]. Clinical Infectious Diseases, 2004(2):161.
|
|
Pfaller M A, Diekema D J. Rare and emerging opportunistic fungal pathogens:concern for resistance beyond Candida albicans and Aspergillus fumigatus [J]. Journal of Clinical Microbiology, 2004, (10):4419.
|
|
Mikamo H, Sato Y, Tamaya T. In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide [J]. Journal of Antimicrobial Chemotherapy, 2000(3):485.
|
|
乔建军, 刘伟, 李若瑜. 米卡芬净对分离自中国的念珠菌和曲霉临床株体外抑菌活性的研究 [J]. 中国真菌学杂志, 2007(1):5.doi: 10.3969/j.issn.1673-3827.2007.01.002.
|
|
De Wet N T, Bester A J, Viljoen J J. A randomized, double blind, comparative trial of micafungin (FK463) vs.fluconazole for the treatment of oesophageal candidiasis [J]. Alimentary Pharmacology and Therapeutics, 2005(7):899.
|
|
Kohno S, Masaoka T, Yamaguchi H. A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan [J]. Scandinavian Journal of Infectious Diseases, 2004(5):372.
|
|
Ernst E J, Roling E E, Petzold C R. In vitro activity of micafungin (FK-463) against Candida spp.:microdilution, time-kill, and postantifungal-effect studies [J]. Antimicrobial Agents and Chemotherapy, 2002, (12):3846.
|
百度学术
下载:
苏公网安备 32100302010246号
